A systematic review on anti-diabetic action of 7-<i>O</i>-galloyl-D-sedoheptulose, a polyphenol from Corni Fructus, in type 2 diabetic mice with hepatic and pancreatic damage-Reference-Cited by-同舟云学术

A systematic review on anti-diabetic action of 7-<i>O</i>-galloyl-D-sedoheptulose, a polyphenol from Corni Fructus, in type 2 diabetic mice with hepatic and pancreatic damage

Published:2023-06-30 Issue:3 Volume:17 Page:151-156
ISSN:1881-7831
Container-title:Drug Discoveries & Therapeutics
language:en
Short-container-title:DD&T

Author:

Park Chan Hum¹,Noh Jeong Sook²,Jeon Jin Pyeong³,Yokozawa Takako⁴

Affiliation:

1. Institute of New Frontier Research Team, Research Institute of Medical-Bio Convergence, Hallym University, Chuncheon, Republic of Korea.

2. Department of Food Science and Nutrition, Tongmyong University, Busan, Republic of Korea.

3. Department of Neurosurgery, College of Medicine, Hallym University, Chuncheon, Republic of Korea.

4. Graduate School of Science and Engineering for Research, University of Toyama, Toyama, Japan.

Publisher

International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.jstage.jst.go.jp/article/ddt/17/3/17_2022.01097/_pdf

Reference42 articles.

1. 1. Narayan KM, Gregg EW, Fagot-Campagna A, Engelgau MM, Vinicor F. Diabetes – a common, growing, serious, costly, and potentially preventable public health problem. Diabetes Res Clin Pract. 2000; 50:S77-S84.

2. 2. Tao T, Deng P, Wang Y, Zhang X, Guo Y, Chen W, Qin J. Microengineered multi-organoid system from hiPSCs to recapitulate human liver-islet axis in normal and type 2 diabetes. Adv Sci. 2022; 9:2103495.

3. 3. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001; 86:1930-1935.

4. 4. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell. 2000; 6:87-97.

5. 5. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes. 2003; 52:1-8.